Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 14, 2023
Harsh fiscal prospects and broader shifts in the health landscape are creating challenges for Gavi’s approach to country eligibility and transition. To date, Gavi’s income-based eligibility model has functioned well during periods of sustained growth in low- and middle-income countries and has helpe...
POLICY PAPERS
December 14, 2023
The prevailing fiscal outlook alongside broader shifts in the health landscape have important implications for countries’ eligibility for support from Gavi, the Vaccine Alliance. Current projections are similar to pre-COVID estimates, but the cohort of transitioning countries face more challenging ...
Blog Post
December 11, 2023
The World Bank offered up several new climate commitments at COP, including that 45 percent of its annual financing will be devoted to climate-related projects. The question is: what does “climate-related” mean? Will these funds really influence climate outcomes, or will they be the financial equiva...
Blog Post
December 11, 2023
With today being Universal Health Coverage (UHC) Day, many stakeholders are rightly concerned about the stalling progress towards the Sustainable Development Goal (SDG3)—"Good Health and Well-being,” of which UHC is an integral part. Since many SDG indicators of progress are outcome-focused, they ca...
POLICY PAPERS
December 11, 2023
Factors like borrowing costs and access to alternative sources of finance will likely limit country demand for World Bank climate mitigation finance absent financial incentives, which could prove costly and difficult to resource at the scale needed to have meaningful impact. There's a risk that thes...
Blog Post
December 04, 2023
In the aftermath of the COVID-19 pandemic, Gavi faces an unprecedented situation. Billions of dollars that it raised back in 2022 for COVAX—the global effort to provide COVID-19 vaccines to lower-income countries—remain unspent. These resources are substantial, exceeding the entire annual budget of ...
Blog Post
December 01, 2023
When Gavi’s board meets in Accra, Ghana, next week, advancing discussions on a new five-year strategic period, known as “Gavi 6.0,” will be a top agenda item. But conversations about Gavi’s future direction are also taking place against the backdrop of a leadership transition and a rapidly changing ...
Blog Post
November 29, 2023
Regulation plays a vital role in ensuring the quality, safety, and efficacy of vaccines—and a strong regulatory system is key to successfully expanding vaccine manufacturing. The Gavi Secretariat is currently fine-tuning the design of a new Advance Market Commitment (AMC)—a financial mechanism to su...